No association between polymorphisms of methylenetetrahydrofolate reductase gene and schizophrenia in both Chinese and Scottish populations Patients with severe MTHFR deficiency have a range of vascular and schizophrenia-like disturbances with a variable age at onset. A common mutation C677T in the MTHFR gene is responsible for the reduced enzyme activity of MTHFR. 1 The CT/TT genotype is associated with increased risk of neural tube defects in association with first trimester prenatal malnutrition. 2 Evidence from Dutch hunger winter has indicated that first trimester prenatal nutritional deficiency is also associated with increased risk of schizophrenia. In light of a possible association of MTHFR with schizophrenia, several studies have examined the common C677T variant as a risk factor for schizophrenia; however, discrepant results have been observed between schizophrenia and the 677 TT genotype. Another common mutation A1298C by itself does not cause hyperhomocysteinemia as compared to the C677T variant. 3 However, combined heterozygosity for the A1298C and C677T variant (AC/CT) may be associated with reduced MTHFR specific activity and hyperhomocysteinemia. 3 Only one study to date has investigated the A1298C variant in schizophrenia 4 and no association was found with this variant in Caucasians. However, they did report an increased frequency of the 677TT.
In the present study, we have examined both C667T and A1298C variants in two large racially distinct populations using two sets of analyses to try to resolve these conflicting results. In the Han Chinese population, DNA samples from 230 unrelated cases with schizophrenia or schizoaffective disorder and 251 controls from Shanghai were examined. A total of 267 schizophrenic probands and their biological parents from Sichuan province were also examined using transmission disequilibrium test (TDT) analysis. At the same time, we have investigated a large set of well-characterized case-control samples from the Scottish population with European ancestry. Subjects were 426 cases and 628 control individuals. Two senior psychiatrists made clinical diagnosis. All Chinese and Scottish cases met the DSM-III-R criteria for schizophrenia or schizoaffective disorder. Written informed consents were obtained from all patients or their relatives and control individuals. The two variants were genotyped by using standard PCR-RFLP analysis. The primers and the procedures were performed as per the methods of Frosst et al 1 and ven der Put et al, 3 respectively. All the genotypic distributions were in HardyWeinberg equilibrium (P40.05). Differences of allele and genotype distribution between patient and control groups were assessed by the Monte Carlo method using the CLUMP program version 2.2 with 10 000 simulations. 5 There were no significant differences in allele or genotype frequencies for the C677T and A1298C variants between cases and controls in both Chinese and Scottish populations. Haplotypes of patients and controls were constructed by the Bayesian methods, 6 as implemented in the PHASE package version 2.0. We found no significant differences in haplotype distribution between cases and controls in either Chinese (
For the family trios analysis, ETDT 7 was used to perform the TDT for single marker. The results of TDT analysis were negative (C677T:
. The haplotypes were analyzed by TRAMSMIT (version 2.5.4) 8 and no differences were observed (the global P-value of the haplotype for two variants was 0.38) (see Table 1 ).
It is most unlikely that our findings differ from earlier studies because of major ethnic differences. The results do not show any significant differences for the two variants of MTHFR gene between schizophrenia and controls in either our Chinese or Caucasian samples. The clinical heterogeneity of schizophrenia cannot be excluded. In a recent study, Joober 9 and his colleagues suggested that the MTHFR gene is involved in the pathogenesis of schizophrenia, where it is characterized by a good response to neuroleptic medication. We have not attempted to stratify our cases according to response to medication. However, if the effect were substantial, one might expect that the association would still show up in an unstratified sample size several times larger than the one used in the earlier report. Finally, diagnostic differences are unlikely. Our Chinese and Scottish samples are well characterized and met the same criteria.
In conclusion, our results are unambiguous and exclude a major role for these two variants of the MTHFR gene in conferring susceptibility to schizophrenia in both Chinese and Scottish populations. However, there are at least 14 other rare mutations in the MTHFR gene, 10 most of them are associated with minor changes in the enzyme activity of MTHFR, which could in theory play a role in susceptibility to schizophrenia. For reasons of economy, we did not examine those variants in the present study. It is important to note that all the individuals in their studies were born during periods where prenatal nutrition was adequate. It is possible, however, that variants in MTHFR gene may predispose to increased risk of schizophrenia among those conceived during periods of inadequate prenatal nutrition such as during the 1959-61 Chinese famine. Studies examining this possibility are about to begin among Chinese schizophrenics conceived during the famine years. w-(df) and P-value w-(df) and P-value w-(df) and P-value
The global P-value of the haplotype in TDT for two variants was 0.38.
Scientific Correspondence
CART peptide levels are altered by a mutation associated with obesity at codon 34 SIR-CART is a regulated neuropeptide that plays a role in many physiological processes including stress, reward and reinforcement and feeding. [1] [2] [3] Recently, del Giudice et al 4 described a missense mutation at codon 34 of proCART that cosegregated with severe early-onset obesity. Our findings show here for the first time that this mutation has a biochemical effect and alters CART peptide levels in cells.
The Leu34Phe mutation in proCART lies immediately adjacent to a cluster of basic amino acids and was therefore hypothesized to alter proCART processing. 4 Accordingly, we characterized proCART processing using human CART cDNA constructs; one expressed a leucine (wild type) while the other expressed a phenylalanine (mutated). These cDNA constructs were transfected into corticotropic AtT20 cells, a cell line that has often been used to study peptide processing. AtT20 cells also express and process CART peptides. 5, 6 Processing of overexpressed human proCART after transfection with the wild-type and mutant cDNAs was analyzed by Western blotting using an antibody (C4) raised against amino acids 66-89 of human proCART. 7 This antibody detects precursor and active forms of CART peptides. Specificity of CART immunoreactivity was demonstrated by pre-absorbing the antibody with an excess of the immunizing peptide prior to the incubation with the membranes.
In the Western blot shown in Figure 1a , the mobility of authentic CART 42-89 is shown in the left lane (arrow head). Also, we have labeled the prominent bands as P1, P2 and P3. P1 and P2 are precursors that may correspond to human CART 1-89 and CART 10-89, and P3 may be CART 42-89. 7, 8 Very little peptide was found in the lane from untransfected AtT20 cells (lane 1) because more extract would be needed to reveal the different CART species. Transfections increased the amount of CART peptides expressed in the cells, as can be seen in Figure 1a (comparing lane 1 with lanes 2 and 3). Interestingly, there was a reduction in P1, P2 and P3 when AtT20 cells were transfected with the mutated cDNA.
To confirm that P1 and P2 were indeed precursor forms of CART peptides, immunoblots were performed using an antibody (C1) that was raised against amino acids 1-26. This antiserum detects human proCART 1-89 and CART 10-89, but does not detect the smaller processed, active CART 42-89 and CART 49-89 peptides. 9 Figure 1b indeed shows that P1 and P2 are precursors. Further, P1 and P2 were decreased in cells transfected with the mutated cDNA ( Figure 1b , lane 2 vs lane 3). We next tested which peptide species were being secreted into the media. AtT20 cells transfected with the wild or the mutated cDNA secreted the overexpressed CART species, P1 and P2. Interestingly, cells transfected with the mutated cDNA CART precursor species were detected using C1 antibody.
